Results 231 to 240 of about 2,041,612 (343)

Impact of diclofenac risk minimization measures addressing cardiovascular risk on analgesic use in musculoskeletal disorders

British Journal of Clinical Pharmacology, EarlyView.
Aims In 2013, risk minimization measures (RMMs) were introduced in Europe to address the increased cardiovascular risk linked to diclofenac. This study aimed to assess the impact of those RMMs on analgesic use. Methods Primary care data from CPRD GOLD (UK) were used.
Tomas Lasys, Yared Santa‐Ana‐Tellez, Satu J. Siiskonen, Daniala L. Weir, Rolf H. H. Groenwold, Helga Gardarsdottir   +5 more
wiley   +1 more source

Acupotomy for Musculoskeletal Pain: Exploring Therapeutic Potential and Future Directions. [PDF]

J Pain Res
Hu J, Tong H, Zhang J, Jiang L.
europepmc   +1 more source

Combination vs. single‐drug nonprescription analgesics for acute pain management: A narrative review

British Journal of Clinical Pharmacology, EarlyView.
Combining nonprescription analgesics with different mechanisms of action has been proposed as a rational strategy to optimize the management of acute pain. This review assessed the efficacy and safety of nonprescription analgesics, including paracetamol (acetaminophen), metamizole and nonsteroidal anti‐inflammatory drugs (NSAIDs) used in combination vs.
Ali Mobasheri, Bart Morlion, Vidhu Sood Sethi, Mary Cardosa, Oscar Della Pasqua, Pranab Kalita   +5 more
wiley   +1 more source

General practitioners' decision-making strategies in the pharmacological treatment of musculoskeletal pain: A qualitative interview study. [PDF]

Eur J Gen Pract
Kornder N, Hill VJ, Groffebert SN, Becker A, Viniol A, Lindner N.   +5 more
europepmc   +1 more source

A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial Using a Low‐Frequency Magnetic Field in the Treatment of Musculoskeletal Chronic Pain [PDF]

, 2007
Alex W. Thomas, Karissa Graham, Frank S. Prato, Julia McKay, P. M. Forster, Dwight E. Moulin, Sesh Chari   +6 more
openalex   +1 more source

Adverse drug reactions, particularly liver disorders, drive interruptions in anti‐tuberculosis treatment: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a key driver of missed doses of anti‐tuberculosis (TB) therapy. We aimed to determine the relative burden of ADR‐driven missed doses, the missed dose patterns associated with ADRs, and the association between specific ADRs and missed doses.
Eleanor G. Dixon, Evita Biraua, Edvards Brencsēns, Vitālijs Pašuks, Vija Riekstina, Anete Šperberga, Marisa D. Muckian, James W. Dear, Liga Kuksa, Derek J. Sloan, Helen R. Stagg   +10 more
wiley   +1 more source

The Use of Non-Invasive Brain Stimulation for the Management of Chronic Musculoskeletal Pain: Fad or Future? [PDF]

Brain Sci
Patricio P, Massé-Alarie H.
europepmc   +1 more source

Hypervigilance and Attentional Fixedness in Chronic Musculoskeletal Pain: Consistency of Findings Across Modified Stroop and Dot-probe Tasks

, 2005
Gordon J. G. Asmundson, Kristi D. Wright, Heather D. Hadjistavropoulos   +2 more
openalex   +1 more source

Preliminary evaluation of a multidisciplinary pain management program for children and adolescents with chronic musculoskeletal pain [PDF]

, 2007
Alida C. E. de Blécourt, Henrica R. Schiphorst Preuper, Cees P. van der Schans, Johan W. Groothoff, Michiel F. Reneman   +4 more
openalex   +1 more source

Deciphering the skeletal interoceptive circuitry to control bone homeostasis

BMEMat, EarlyView.
This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu, Jiusi Guo, Zhen Chen, Fengwei Zhang, Billy Kwok Chong Chow, Zhuofan Chen, Kelvin Wai‐Kwok Yeung, Wei Qiao   +7 more
wiley   +1 more source